NeOnc Technologies Redeems All $6M Series A Preferred Stock

Seeking Alpha·17 Sep 2026·

·Read original

2▲0 ▼0Impact / 5

Corporate Action Price Action Pharmaceuticals

NTHI ±

Summary · why it matters

NeOnc Technologies said Thursday that it had redeemed all 6,000 outstanding Series A preferred shares for $6M. The redemption was funded with part of the proceeds from the company's $15M registered direct offering announced Sept. 9. The company had issued the Series A preferred stock for $5M in June, with a conversion feature carrying a 20% discount to the applicable market price. Shares fell 9.67%.

NeOnc Technologies Holdings, Inc. Common Stock ±

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks

NeOnc Technologies Holdings, Inc. Common Stock

NTHI

± MixedCapitalrelevance

NeOnc redeemed all $6M Series A preferred stock using proceeds from its $15M registered direct offering, a capital-structure event with mixed implications.

NeOnc Technologies Redeems All $6M Series A Preferred Stock

Impact on assets 1

Theme Impact

Off-coverage companies

Related news